Original Article

The Effect of C-X-C Motif Chemokine Ligand 12 in Colorectal Cancer Associated with Chemoresistance and Radioresistance as Well as Stemness

Abstract

Background: We aimed to explore the role of C-X-C motif chemokine ligand 12 (CXCL12) and cytokine-cytokine receptor interaction signaling pathway in the radiotherapy and chemotherapy resistance as well as cell stemness in colorectal cancer (CRC).
Methods: Bioinformatics analysis was used to identify the differentially expressed mRNAs and signal pathways closely related to differentially expressed mRNAs have also been analyzed in March 2022 at the Jinhua Central Hospital, China. Then, the expression of CXCL12 was detected by qRT-PCR in colorectal cancer cells and testing the effects of transfecting CXCL12 into different CRC-derived cell lines. The effects of CXCL12 on cell proliferation were evaluated by chemosensitivity assay and radiation sensitivity assay.
Results: Bioinformatics analysis of DEGs found a total of 2429 differentially expressed genes, THBS3 and CXCL12 genes are two abnormally highly expressed genes in the CRC. KEGG analysis showed the correlative signaling pathway, cytokine-cytokine receptor interaction, which is related to cell stemness. Furthermore, the expression of CXCL12 in CRC cells was detected and an increasing trend was obtained in CRC cells. In addition, the chemosensitivity and radiotherapy tolerance were elevated after transfected with CXCL12.
Conclusion: CXCL12 could be a potential promote biomarkers in CRC and also promote the chemosensitivity and radiotherapy tolerance.

1. Malki A, ElRuz RA, Gupta I, Allouch A, Vranic S, Al Moustafa AE (2020). Molecular Mechanisms of Co-lon Cancer Progression and Metastasis: Recent In-sights and Advancements. Int J Mol Sci, 22(1):130.
2. Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB (2019). Colorectal cancer. Lancet, 394(10207):1467-1480.
3. Mármol I, Sánchez-de-Diego C, Pradilla Dieste A, Cer-rada E, Rodriguez Yoldi MJ (2017). Colorectal Car-cinoma: A General Overview and Future Perspec-tives in Colorectal Cancer. Int J Mol Sci, 18(1):197.
4. Kuipers EJ, Grady WM, Lieberman D, et al (2015). Colorectal cancer. Nat Rev Dis Primers, 1:15065.
5. Pajonk F, Vlashi E, McBride WH (2010). Radiation re-sistance of cancer stem cells: the 4 R's of radiobiol-ogy revisited. Stem Cells, 28(4):639-48.
6. Vega P, Valentín F, Cubiella J (2015). Colorectal cancer diagnosis: Pitfalls and opportunities. World J Gastroin-test Oncol, 7(12):422-33.
7. Kreso A, Dick JE (2014). Evolution of the cancer stem cell model. Cell Stem Cell, 14(3):275-91.
8. Prasetyanti PR, Medema JP (2017). Intra-tumor hetero-geneity from a cancer stem cell perspective. Mol Cancer, 16(1):41.
9. Meerson A, Khatib S, Mahajna J (2021). Natural Prod-ucts Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics. Int J Mol Sci, 22(23):13044.
10. Das PK, Zahan T, Abdur Rakib M, Khanam JA, Pillai S, Islam F (2019). Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy. Anticancer Agents Med Chem, 19(15):1796-1808.
11. De Angelis ML, Francescangeli F, Zeuner A, Baiocchi M (2021). Colorectal Cancer Stem Cells: An Over-view of Evolving Methods and Concepts. Cancers (Basel), 13(23):5910.
12. Yamashita T, Ji J, Budhu A, et al (2009). EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterolo-gy, 136(3):1012-24.
13. Paolillo M, Colombo R, Serra M, et al (2019). Stem-Like Cancer Cells in a Dynamic 3D Culture System: A Model to Study Metastatic Cell Adhesion and Anti-Cancer Drugs. Cells, 2019, 8(11):1434.
14. Ren Y, Deng R, Cai R, et al (2020). TUSC3 induces drug resistance and cellular stemness via Hedgehog sig-naling pathway in colorectal cancer. Carcinogenesis, 41(12):1755-1766.
15. Rawla P, Sunkara T, Barsouk A (2019). Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol, 14(2):89-103.
16. Teicher BA, Fricker SP (2010). CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res, 16(11):2927-31.
17. Miller MC, Mayo KH (2017). Chemokines from a Struc-tural Perspective. Int J Mol Sci, 18(10):2088.
18. Sun X, Cheng G, Hao M, et al (2010). CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev, 29(4):709-22.
19. Ray P, Stacer AC, Fenner J, et al (2015). CXCL12-γ in primary tumors drives breast cancer metastasis. On-cogene, 34(16):2043-51.
20. Samarendra H, Jones K, Petrinic T, et al (2017). A meta-analysis of CXCL12 expression for cancer progno-sis. Br J Cancer, 117(1):124-135.
21. Hummel R, Hussey DJ, Haier J (2010). MicroRNAs: predictors and modifiers of chemo- and radio-therapy in different tumour types. Eur J Cancer, 46(2):298-311.
22. Cui SY, Huang JY, Chen YT, et al (2013). Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma. Mol Cancer Res, 11(7):699-713.
23. Smith JA, Wild AT, Singhi A, et al (2012). Clinicopatho-logic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradio-therapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal Cancer. Int J Surg Oncol, 2012:406568.
24. Kishore C, Sundaram S, Karunagaran D (2019). Vita-min K3 (menadione) suppresses epithelial-mesenchymal-transition and Wnt signaling path-way in human colorectal cancer cells. Chem Biol In-teract, 309:108725.
25. Kim K, Wu HG, Jeon SR (2015). Epidermal growth factor-induced cell death and radiosensitization in epidermal growth factor receptor-overexpressing cancer cell lines. Anticancer Res, 35(1):245-53.
26. Xiong Y, Shao L, Liu J, et al (2021). The Evolving Strate-gy of Californium-252 Neutron Intracavitary Brachytherapy in Treating Patients With Low-Lying T2 or T3 Rectal Adenocarcinoma: From Fixed to Individualized Regime With Intrarectal Peritumoral Injection of Amifostine. Front Oncol, 11:758698.
27. Altanerova U, Jakubechova J, Benejova K, et al (2019). Prodrug suicide gene therapy for cancer targeted in-tracellular by mesenchymal stem cell exosomes. Int J Cancer, 144(4):897-908.
Files
IssueVol 53 No 9 (2024) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijph.v53i9.16461
Keywords
Colorectal cancer (CRC) C-X-C motif chemokine ligand 12 (CXCL12) Chemosensitivity Radiation-sensitivity Stemness
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Dong W, Lin W, Li C. The Effect of C-X-C Motif Chemokine Ligand 12 in Colorectal Cancer Associated with Chemoresistance and Radioresistance as Well as Stemness. Iran J Public Health. 2024;53(9):2079-2089.